Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PASG compared with TCRX: revenue, margins and what each company keeps, and the suppliers and customers both name
PASG
Passage BIO, Inc.
Change
Mkt cap
Revenue
Revenue
TCRX
TScan Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
PASG
Passage BIO, Inc.
vs
TCRX
TScan Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only PASG
1
—
Gemma
unlisted
supplier
Shared
0
No shared counterparties.
Only TCRX
4
AMGN
Amgen
customer
NVS
Novartis
customer
—
Brigham and Women's Hospital, Inc. (BWH)
unlisted
supplier
—
Phsa
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
unlisted
supplier
PASG
Passage BIO, Inc.
Change
3.50
▲
+1.45%
Mkt cap
$11.1M
Revenue
$99,000
Q3 FY24
Revenue
—
TCRX
TScan Therapeutics, Inc.
Change
0.18
▲
+3.55%
Regular session
Nov 2 '26
Mkt cap
$11.8M
Revenue
$1M
Q2 FY26
Revenue
$10M
FY25
vs
Compare
Regular session
Nov 2 '26
PASG
Passage BIO, Inc.
vs
TCRX
TScan Therapeutics, Inc.
3.50
▲
+1.45%
Price
0.18
▲
+3.55%
$11.1M
Mkt cap
$11.8M
Q3 FY24
$99,000
Revenue
$1M
Q2 FY26
—
Revenue
$10M
FY25
Change
Change
PASG
3.50
▲
+1.45%
vs
TCRX
0.18
▲
+3.55%
Regular session
Nov 2 '26